Article 12: Understanding the Difference Between a Strategic Buyer and a Private Equity Group

By: The MidCap Healthcare Team

Two Very Different Buyer Types: In the OB/GYN M&A market, practice owners will primarily encounter two categories of buyers: strategic buyers (typically hospital systems, health networks, or larger physician group consolidators) and financial buyers (private equity sponsors). Understanding the fundamental differences between these buyer categories in terms of their objectives, deal structures, operational philosophies, and financial capacity is essential to evaluating any offer and selecting the right partner for your post-transaction professional life.

Strategic Buyers: Integration and Synergy

Strategic buyers are acquiring practices because the addition creates operational or strategic value for their existing enterprise. A hospital system acquiring an OB/GYN practice is typically seeking to control referral patterns, integrate the practice into its employed physician network, and leverage the practice’s patient base to drive utilization of the system’s inpatient and ancillary services. Strategic buyers can sometimes justify higher prices when synergies are significant, but they are also acquiring to integrate, which typically means the practice will be absorbed into the buyer’s operational model, governance structure, and compensation system. Clinical autonomy and practice culture are frequent casualties of strategic acquisitions.

Private Equity Buyers: Growth and Returns

Private equity groups are financial investors that acquire physician practices as part of a broader value-creation strategy. They are not acquiring to integrate into an existing operational infrastructure—they are acquiring to build a platform, grow EBITDA over a 3-to-7-year holding period, and ultimately sell the larger, more valuable platform to a subsequent buyer (often a larger PE fund or strategic acquirer). Because PE sponsors are underwriting future growth, not current synergies, they price acquisitions primarily on normalized EBITDA multiples and are motivated to present deal terms that retain physician talent and incentivize continued clinical productivity through rollover equity and attractive post-closing compensation.

Culture, Control, and Clinical Autonomy

One of the most significant differentiators between strategic and PE buyers is the degree of operational control and cultural preservation that each model offers. Strategic buyers, particularly hospital systems, tend to be more prescriptive about employment arrangements, governance, and clinical protocols. PE-backed platforms, by contrast, often market themselves on their commitment to preserving physician autonomy and practice culture, at least in the near term. In practice, the degree of autonomy varies significantly across PE sponsors and platforms, and physician-owners should speak directly with physicians at other practices within any PE platform under consideration before making a decision.

Which Is Right for Your Practice?

The optimal buyer type depends heavily on the age composition of your physician group, your financial objectives, your post-transaction professional goals, and your practice’s strategic position in the local market. A group of physicians who are 5 to 10 years from retirement, with significant rollover equity upside, may find a PE transaction more financially compelling. A group whose founder is closer to full retirement and values income stability and the elimination of business risk may find strategic employment more attractive. Running a competitive process rather than negotiating exclusively with one buyer type remains the most reliable strategy for ensuring you achieve the best possible outcome across all dimensions.